LifeVantage Appoints New Chief Executive Officer
April 29 2015 - 9:00AM
LifeVantage Corporation (Nasdaq:LFVN), announced today that Darren
Jensen has been named President and Chief Executive Officer for the
company. Mr. Jensen's appointment is effective May 18, 2015.
Mr. Jensen most recently served as President of the Americas and
Chief Sales Officer at Jeunesse Global, a personal care and
nutrition network marketing company. During his tenure at Jeunesse,
the company was ranked #258 on The 2014 Inc. 500 with 1788% revenue
growth over a three-year period, and was the fastest growing Direct
Selling Association company in America for 2014.
"LifeVantage is uniquely positioned as one of the leading
product-driven business opportunities available," said Jensen. "I
am honored and delighted to work together with our independent
distributors to execute our vision of bringing that opportunity to
the world."
Jensen brings 25 years of global network marketing and direct
selling experience to LifeVantage from companies selling a variety
of product types including nutritional supplements and personal
care products. In addition to his tenure at Jeunesse Global, Mr.
Jensen previously served in senior roles at USANA Health Sciences,
Synergy Worldwide, Amway Global, and Nu Skin Enterprises. In these
roles he led the development and execution of global sales, product
development and service expansion strategies. He was responsible
for international business development, performance improvement,
and global marketing efforts in more than 100 countries within the
Asia Pacific Rim, Latin America, the Caribbean, Europe, the Middle
East, and Africa.
"Darren Jensen is a well-known and a respected visionary leader
in the global network marketing and direct selling industry," said
Garry Mauro, Chairman of the Board of Directors for LifeVantage
Corporation. "The Board quickly recognized that Darren's
unparalleled track record of success with leading the development
and execution of business expansion and sales growth strategies
makes him the right leader for LifeVantage."
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science based
network marketing company dedicated to visionary science that looks
to transform health, wellness and anti-aging internally and
externally at the cellular level. The company is the maker of
Protandim®, the Nrf2 Synergizer® patented dietary supplement, the
TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, and the
AXIO™ energy product line. LifeVantage was founded in 2003 and is
headquartered in Salt Lake City, Utah.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe," "hopes," "intends," "estimates,"
"expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but
their absence does not mean that a statement is not
forward-looking. Examples of forward-looking statements include,
but are not limited to, statements we make regarding our leadership
transition, future growth and distributor success. Such
forward-looking statements are not guarantees of performance and
the Company's actual results could differ materially from those
contained in such statements. These forward-looking statements are
based on the Company's current expectations and beliefs concerning
future events affecting the Company and involve known and unknown
risks and uncertainties that may cause the Company's actual results
or outcomes to be materially different from those anticipated and
discussed herein. These risks and uncertainties include, among
others, those discussed in greater detail in the Company's Annual
Report on Form 10-K and the Company's Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by
the Company from time to time with the Securities and Exchange
Commission. The Company cautions investors not to place undue
reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after
the date of this document, except as required by law.
CONTACT: Investor Relations Contacts:
Cindy England (801) 432-9036
Director of Investor Relations
-Or-
John Mills (646) 277-1254
Partner, ICR INC
Company Relations Contact:
John Genna (801) 432-9172
Vice President of Communications &
Corporate Partnerships
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024